scholarly article | Q13442814 |
P356 | DOI | 10.1002/HEP.510250327 |
P698 | PubMed publication ID | 9049214 |
P2093 | author name string | Tusch G | |
Müller MJ | |||
Selberg O | |||
Böttcher J | |||
Pichlmayr R | |||
Henkel E | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
liver transplantation | Q1368191 | ||
P304 | page(s) | 652-657 | |
P577 | publication date | 1997-03-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. | |
P478 | volume | 25 |
Q35054956 | Assessment of nutritional status in organ transplant: is transthyretin a reliable indicator? |
Q45399183 | Assessment of nutritional status of patients with hepatitis C virus-related liver cirrhosis |
Q34774434 | Cachexia in liver cirrhosis |
Q34067831 | Changes in nutritional status after liver transplantation |
Q55322856 | Changes of Intestinal Functions in Liver Cirrhosis. |
Q77738191 | Clinical implications of altered energy metabolism in patients with cirrhosis |
Q79787945 | Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis |
Q24310702 | Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis |
Q43831134 | Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation |
Q51932612 | Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. |
Q37794228 | Does living donation have advantages over deceased donation in liver transplantation? |
Q50694089 | Effect of a late evening snack on outpatients with liver cirrhosis. |
Q81313146 | Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis |
Q44912010 | Effects of post-transplant enteral nutrition with an immunomodulating diet containing hydrolyzed whey peptide after liver transplantation |
Q47421573 | Estimation of liver size for liver transplantation: the impact of age and gender |
Q41879085 | Estimation of protein intake using urinary urea nitrogen in patients with early-stage liver cirrhosis |
Q52381380 | Evaluation of Factors Associated with Hypermetabolism and Hypometabolism in Critically Ill AKI Patients. |
Q36506097 | Examining the role of tube feeding after liver transplantation |
Q79862726 | FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2 |
Q46052614 | Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation. |
Q37558167 | Functional body composition: insights into the regulation of energy metabolism and some clinical applications |
Q38263849 | Gastrointestinal dysfunction in liver cirrhosis |
Q51910184 | Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. |
Q37727130 | Handheld calorimeter is a valid instrument to quantify resting energy expenditure in hospitalized cirrhotic patients: a prospective study |
Q40872378 | Hepatic energy and substrate metabolism: a possible metabolic basis for early nutritional support in cirrhotic patients |
Q37481692 | Hepatology - Guidelines on Parenteral Nutrition, Chapter 16. |
Q36888140 | High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation |
Q88766860 | Impact of Enteral Nutrition with an Immunomodulating Diet Enriched with Hydrolyzed Whey Peptide on Infection After Liver Transplantation |
Q35933774 | Impact of body mass index on graft failure and overall survival following liver transplant |
Q53110843 | Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. |
Q51319674 | Increased intestinal permeability in malnourished patients with liver cirrhosis. |
Q35768917 | Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats |
Q41695656 | Insulin-like growth factor-I in liver cirrhosis |
Q61443531 | Interventions to improve sarcopenia in cirrhosis: A systematic review |
Q37946494 | Late evening snack: exploiting a period of anabolic opportunity in cirrhosis |
Q36542789 | Liver transplantation for cirrhosis in cystic fibrosis |
Q74106559 | Low HLA-DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake |
Q40813510 | Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease |
Q51563956 | Macronutrient preference, dietary intake, and substrate oxidation among stable cirrhotic patients. |
Q33867959 | Malnutrition affects quality of life in gastroenterology patients |
Q37982868 | Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses |
Q34996959 | Malnutrition is a risk factor in cirrhotic patients undergoing surgery |
Q35883201 | Metabolomics changes in a rat model of obstructive jaundice: mapping to metabolism of amino acids, carbohydrates and lipids as well as oxidative stress |
Q36120517 | Multicentre, randomised, placebo-controlled trial of extract of Japanese herbal medicine Daikenchuto to prevent bowel dysfunction after adult liver transplantation (DKB 14 Study) |
Q38058001 | Neurological complications post-liver transplantation: impact of nutritional status. |
Q40707333 | Nonalcoholic fatty liver disease following liver transplantation |
Q64980187 | Nutrition Management of Acute Postliver Transplant Recipients. |
Q47300465 | Nutrition and Muscle in Cirrhosis |
Q33780141 | Nutrition and exercise in the management of liver cirrhosis |
Q33784016 | Nutrition and liver transplantation |
Q73999981 | Nutrition and survival in patients with liver cirrhosis |
Q47600945 | Nutrition and the transplant candidate |
Q37124909 | Nutrition assessment and its effect on various clinical variables among patients undergoing liver transplant |
Q34239252 | Nutrition assessment and support of organ transplant recipients |
Q34329819 | Nutrition assessment in patients undergoing liver transplant |
Q29028264 | Nutrition in Hepatic Encephalopathy |
Q74256214 | Nutrition in hepatic failure and liver transplantation |
Q38371556 | Nutrition in the management of cirrhosis and its neurological complications. |
Q38035172 | Nutrition support and infections associated with hepatic resection and liver transplantation in patients with chronic liver disease |
Q26771155 | Nutritional assessment in cirrhotic patients with hepatic encephalopathy |
Q73637547 | Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation |
Q36465324 | Nutritional risk and anthropometric evaluation in pediatric liver transplantation |
Q37613643 | Nutritional status and liver transplantation |
Q38600997 | Nutritional status using subjective global assessment independently predicts outcome of patients waiting for living donor liver transplant |
Q36438775 | Nutritional support in patients with chronic liver disease |
Q73601692 | On the impact of the metabolic state in cirrhotic patients |
Q47741783 | Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis |
Q41742750 | Perioperative immunonutrition in patients undergoing liver transplantation: a randomized double-blind trial. |
Q54302134 | Peritoneovenous shunt as a bridge to liver transplantation. |
Q34142504 | Plasma bile acids are not associated with energy metabolism in humans |
Q96343356 | Preoperative Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of 1-Year Graft Loss and Mortality After Orthotopic Liver Transplantation |
Q36955940 | Pretransplant obesity: a weighty issue affecting transplant candidacy and outcomes |
Q51544352 | Prognostic value of energy metabolism in patients with viral liver cirrhosis. |
Q28087493 | Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications |
Q42866767 | Resting Energy Expenditure and Substrate Metabolism in Chinese Patients with Acute or Chronic Hepatitis B or Liver Cirrhosis |
Q52206400 | Resting energy expenditure should be measured in patients with cirrhosis, not predicted. |
Q35206697 | Review article: Nutritional therapy in alcoholic liver disease |
Q42158270 | Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure. |
Q26780288 | Sarcopenia and liver transplant: The relevance of too little muscle mass |
Q42764616 | Sarcopenia associated with portosystemic shunting is reversed by follistatin |
Q38756962 | Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances. |
Q74372917 | Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgery |
Q42132527 | Serum hepatocyte growth factor as an index of extensive catabolism of patients awaiting liver transplantation |
Q54709855 | Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat. |
Q48031473 | Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis |
Q37481663 | Surgery and transplantation - Guidelines on Parenteral Nutrition, Chapter 18. |
Q38712435 | Systematic Review and Meta-Analysis of the Impact of Computed Tomography-Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation |
Q48467378 | The effect of supplementation with branched-chain amino acids in patients with liver cirrhosis |
Q44997073 | The impact of wait list body mass index changes on the outcome after liver transplantation |
Q37854505 | The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists |
Q37625811 | The management of patients awaiting liver transplantation |
Q51403385 | Total and acylated ghrelin in liver cirrhosis: correlation with clinical and nutritional status. |
Q36565361 | Total parenteral nutrition: challenges and practice in the cirrhotic patient |
Q95443981 | [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): |
Q77790572 | [Liver transplantation in the adult: who and when to transplant?] |
Q52408661 | [Nutritional assessment in patients with cirrhosis: the use of indirect calorimetry]. |
Search more.